Track the NextCell Pharma AB stock price and the full management transaction log of the company, a listed issuer based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, NextCell Pharma AB has recorded 10 public disclosures. Market capitalisation: €109.7m. The latest transaction was disclosed on 3 June 2025 (Other). Among the most active insiders: Patrik Fagerholm. All data is accessible without an account.
10
Insider Decl.
n/a
Thresholds
€1,196
3 ops.
Buy Volume
€93,715
1 ops.
Sell Volume
42Σ signal
Buys €1,196€93,715 Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.